Autoimmunity and heart diseases: pathogenesis and diagnostic criteria

Review

Abstract

Autoimmunity may evolve in predisposed individuals following an exogenous trigger. Autoimmunity is affected by genetic, immune, hormonal, and environmental factors. Immune mechanisms in heart diseases are complex and often not completely understood. Several cardiac disorders are believed to be mediated by an immune reaction. Both humoral and cellular immunity are associated with the development of myocarditis, dilated cardiomyopathy, heart failure, rheumatic fever, and atherosclerosis. Here the diagnostic criteria and autoimmune aspects of autoimmune-mediated cardiac disorders are reviewed. New diagnostic criteria for “autoimmune dilated cardiomyopathy” were recently suggested by the authors. They presume that establishing a dominant autoimmune etiology in some patients will have clinical significance because these patients will potentially gain the greatest benefit from immunosuppressive and immunomodulating treatments.

Keywords

autoantibodies myocarditis autoimmune dilated cardiomypathy atherosclerosis rheumatic fever 

References

  1. (1992) Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268: 2069-2073Google Scholar
  2. (2004): Rheumatic fever and rheumatic heart disease: Report of a WHO expert consultation, Geneva, 29 October–November 2001 World Health Organ Tech Rep Ser, 923Google Scholar
  3. Afanasyeva M, Georgakopoulos D, Rose NR (2004) Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev 3: 476-486CrossRefPubMedGoogle Scholar
  4. Afek A, George J, Gilburd B et al (2000) Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 14: 115-121CrossRefPubMedGoogle Scholar
  5. Aukrust P, Yndestad A, Ueland T et al (2006) The role of intravenous immunoglobulin in the treatment of chronic heart failure. Int J Cardiol 112: 40-55CrossRefPubMedGoogle Scholar
  6. Belizna CC, Richard V, Thuillez C et al (2007) Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev 7: 46-51CrossRefPubMedGoogle Scholar
  7. Caforio AL, Daliento L, Angelini A et al (2005) Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies. Lupus 14: 652-655CrossRefPubMedGoogle Scholar
  8. Caforio AL, Mahon NG, Baig MK et al (2007) Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115: 76-83CrossRefPubMedGoogle Scholar
  9. Caforio AL, Vinci A, Iliceto S (2008) Anti-heart autoantibodies in familial dilated cardiomyopathy. Autoimmunity 41: 462-469CrossRefPubMedGoogle Scholar
  10. Carapetis JR, McDonald M, Wilson NJ (2005) Acute rheumatic fever. Lancet 366: 155-168CrossRefPubMedGoogle Scholar
  11. Celis R, Torre-Martinez G, Torre-Amione G (2008) Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?. Curr Opin Cardiol 23: 254-260CrossRefPubMedGoogle Scholar
  12. Cilliers AM (2006) Rheumatic fever and its management. BMJ 333: 1153-1156CrossRefPubMedGoogle Scholar
  13. de Leeuw K, Kallenberg C, Bijl M (2005) Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci 1051: 362-371CrossRefPubMedGoogle Scholar
  14. Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564-1575CrossRefPubMedGoogle Scholar
  15. Desai A, Fang JC (2008) Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy. Heart Fail Clin 4: 87-97CrossRefPubMedGoogle Scholar
  16. Dorffel WV, Wallukat G, Baumann G et al (2000) Immunoadsorption in dilated cardiomyopathy. Ther Apher 4: 235-238CrossRefPubMedGoogle Scholar
  17. Elliott P (2000) Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy. Heart 84: 106-112CrossRefPubMedGoogle Scholar
  18. Eriksson U, Penninger JM (2005) Autoimmune heart failure: new understandings of pathogenesis. Int J Biochem Cell Biol 37: 27-32CrossRefPubMedGoogle Scholar
  19. Eriksson U, Ricci R, Hunziker L et al (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9: 1484-1490CrossRefPubMedGoogle Scholar
  20. Fae KC, Oshiro SE, Toubert A et al (2005) How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24: 101-109CrossRefPubMedGoogle Scholar
  21. Felix SB, Staudt A (2008) Immunoadsorption as treatment option in dilated cardiomyopathy. Autoimmunity 41: 484-489CrossRefPubMedGoogle Scholar
  22. Frantz S, Bauersachs J, Kelly RA (2005) Innate immunity and the heart. Curr Pharm Des 11: 1279-1290CrossRefPubMedGoogle Scholar
  23. Fu M (2008) Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?. Autoimmunity 41: 415-418CrossRefPubMedGoogle Scholar
  24. George J, Harats D, Gilburd B et al (2000) Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102: 1822-1827PubMedGoogle Scholar
  25. Gong KZ, Song G, Spiers JP et al (2007) Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches. Int J Clin Pract 61: 611-621CrossRefPubMedGoogle Scholar
  26. Guilherme L, Fae KC, Oshiro SE et al (2007) T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins. Curr Protein Pept Sci 8: 39-44CrossRefPubMedGoogle Scholar
  27. Guilherme L, Kalil J (2004) Rheumatic fever: from sore throat to autoimmune heart lesions. Int Arch Allergy Immunol 134: 56-64CrossRefPubMedGoogle Scholar
  28. Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39: 31-49CrossRefPubMedGoogle Scholar
  29. Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112: 7-14CrossRefPubMedGoogle Scholar
  30. Jahns R, Boivin V, Schwarzbach V et al (2008) Pathological autoantibodies in cardiomyopathy. Autoimmunity 41: 454-461CrossRefPubMedGoogle Scholar
  31. Jane-wit D, Tuohy VK (2006) Autoimmune cardiac-specific T cell responses in dilated cardiomyopathy. Int J Cardiol 112: 2-10CrossRefPubMedGoogle Scholar
  32. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348: 2007-2018CrossRefPubMedGoogle Scholar
  33. Kallwellis-Opara A, Dorner A, Poller WC et al (2007) Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 96: 469-480CrossRefPubMedGoogle Scholar
  34. Krebs P, Kurrer MO, Kremer M et al (2007) Molecular mapping of autoimmune B cell responses in experimental myocarditis. J Autoimmun 28: 224-233CrossRefPubMedGoogle Scholar
  35. Levin MJ, Hoebeke J (2008) Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas-heart disease. Autoimmunity 41: 429-433CrossRefPubMedGoogle Scholar
  36. Li HS, Ligons DL, Rose NR (2008) Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7: 168-173CrossRefPubMedGoogle Scholar
  37. Li Y, Heuser JS, Cunningham LC et al (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177: 8234-8240PubMedGoogle Scholar
  38. Liang CS, Mao W, Liu J (2008) Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway. Autoimmunity 41: 434-441CrossRefPubMedGoogle Scholar
  39. Limas CJ, Iakovis P, Anyfantakis A et al (2004) Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 93: 1189-1191CrossRefPubMedGoogle Scholar
  40. Lindberg E, Magnusson Y, Karason K et al (2008) Lower levels of the host protective IL-10 in DCM — a feature of autoimmune pathogenesis?. Autoimmunity 41: 478-483CrossRefPubMedGoogle Scholar
  41. Mascaro-Blanco A, Alvarez K, Yu X et al (2008) Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 41: 442-453CrossRefPubMedGoogle Scholar
  42. Matsuura E, Kobayashi K, Koike T et al (2002) Autoantibody-mediated atherosclerosis. Autoimmun Rev 1: 348-353CrossRefPubMedGoogle Scholar
  43. Mestroni L, Maisch B, McKenna WJ et al (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 20: 93-102CrossRefPubMedGoogle Scholar
  44. Mobini R, Maschke H, Waagstein F (2004) New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 3: 277-284CrossRefPubMedGoogle Scholar
  45. Muller II, Klingel K, Nikolaev VO et al (2008) Immunoadsorption in a 40 year old man with dilated cardiomyopathy and underlying active myocarditis. Clin Res Cardiol 97: 787-790CrossRefPubMedGoogle Scholar
  46. Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin — indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7: 445-452CrossRefGoogle Scholar
  47. Nussinovitch U, Shoenfeld Y (2008) Autoimmune Dilated Cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic Criteria for the Autoimmune Diseases, 1st edn. The Humana Press Inc, New Jersey, USAGoogle Scholar
  48. Piepoli MF (2007) Immune activation and inflammatory system in chronic heart failure: novel pathophysiological hypotheses generate new therapeutic options. Int J Clin Pract 61: 536-538CrossRefPubMedGoogle Scholar
  49. Quinn A, Kosanke S, Fischetti VA et al (2001) Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun 69: 4072-4078CrossRefPubMedGoogle Scholar
  50. Rahamim-Cohen D, Shoenfeld Y (2001) The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. Isr Med Assoc J 3: 381-382PubMedGoogle Scholar
  51. Rakar S, Sinagra G, Di Lenarda A et al (1997) Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. Eur Heart J 18: 117-123Google Scholar
  52. Rose NR (2008) Predictors of autoimmune disease: autoantibodies and beyond. Autoimmunity 41: 419-428CrossRefPubMedGoogle Scholar
  53. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14: 426-430CrossRefPubMedGoogle Scholar
  54. Saxena A (2000) Diagnosis of rheumatic fever: current status of Jones Criteria and role of echocardiography. Indian J Pediatr 67: 283-286CrossRefPubMedGoogle Scholar
  55. Sherer Y, Cerinic MM, Bartoli F et al (2007) Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 1108: 259-267CrossRefPubMedGoogle Scholar
  56. Sherer Y, Shoenfeld Y (2002) Immunomodulation for treatment and prevention of atherosclerosis. Autoimmun Rev 1: 21-27CrossRefPubMedGoogle Scholar
  57. Sherer Y, Shoenfeld Y (2008) Rheumatic Fever. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic Criteria for the Autoimmune Diseases, 1st edn. The Humana Press Inc, New Jersey, USAGoogle Scholar
  58. Shoenfeld Y, Blank M, Abu-Shakra M et al (2008a) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases — 2008. Isr Med Assoc J 10: 13-19PubMedGoogle Scholar
  59. Shoenfeld Y, Gerli R, Doria A et al (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112: 3337-3347CrossRefPubMedGoogle Scholar
  60. Shoenfeld Y, Gilburd B, Abu-Shakra M et al (2008b) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases — 2008. Isr Med Assoc J 10: 3-10PubMedGoogle Scholar
  61. Shoenfeld Y, Sherer Y, Harats D (2001) Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 22: 293-295CrossRefPubMedGoogle Scholar
  62. Shoenfeld Y, Zandman-Goddard G, Stojanovich L et al (2008c) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases — 2008. Isr Med Assoc J 10: 8-12PubMedGoogle Scholar
  63. Singh SK, Suresh MV, Voleti B et al (2008) The connection between C-reactive protein and atherosclerosis. Ann Med 40: 110-120CrossRefPubMedGoogle Scholar
  64. Szekanecz Z, Kerekes G, Der H et al (2007) Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci 1108: 349-358CrossRefPubMedGoogle Scholar
  65. Torre-Amione G (2005) Immune activation in chronic heart failure. Am J Cardiol 95:3C-40C; discussion 38C-40CGoogle Scholar
  66. Usalan C, Buyukhatipoglu H, Tiryaki O (2007) Systemic lupus erythematosus complicated by dilated cardiomyopathy and severe heart failure. Clin Rheumatol 26: 125-127CrossRefPubMedGoogle Scholar

Copyright information

© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2009

Authors and Affiliations

  1. 1.Department of Medicine “B”Chaim Sheba Medical CenterTel-HashomerIsrael
  2. 2.Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune DiseasesTel-Aviv UniversityTel-AvivIsrael

Personalised recommendations